[Methods for the control of pulmonary hemorrhage]

Area of Science:

• Pulmonology
• Pathophysiology
• Vascular Biology

Context:

• Pulmonary hemorrhage (PH) is a serious complication in various lung diseases, including tuberculosis, chronic lung conditions, and cancer.
• Existing literature provides data on PH incidence but lacks comprehensive understanding of its pathogenesis and effective management strategies.

Purpose:

• To review existing literature on the incidence and causes of pulmonary hemorrhage.
• To present novel insights into the pathogenesis of PH, emphasizing the roles of pulmonary hypertension and aneurysmal vascular remodeling.
• To describe a staged system for controlling PH, encompassing medical and surgical interventions.

Summary:

• This paper synthesizes current knowledge on pulmonary hemorrhage (PH) incidence across diverse lung pathologies.
• It introduces new evidence implicating pulmonary hypertension and vascular abnormalities in PH development.
• A comprehensive, staged approach to hemostasis is detailed, integrating pro-coagulant strategies, anti-fibrinolytic measures, endobronchial/endovascular techniques, and surgical options.
• The review also describes a method for inducing artificial controlled hypotonia using drug-induced ganglionic blockade.

Impact:

• Provides a consolidated understanding of pulmonary hemorrhage pathogenesis and contributing factors.
• Offers a structured framework for managing pulmonary hemorrhage, potentially improving patient outcomes.
• Highlights the significance of addressing pulmonary hypertension and vascular anomalies in PH treatment.
• Introduces a specific technique for controlled hypotension to aid in bleeding arrest.